rs3741983

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002834.5(PTPN11):​c.1600-95C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.256 in 938,236 control chromosomes in the GnomAD database, including 47,731 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). The gene PTPN11 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.37 ( 15327 hom., cov: 32)
Exomes 𝑓: 0.23 ( 32404 hom. )

Consequence

PTPN11
NM_002834.5 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.93

Publications

15 publications found
Variant links:
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]
PTPN11 Gene-Disease associations (from GenCC):
  • LEOPARD syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • metachondromatosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002834.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 12-112502049-C-T is Benign according to our data. Variant chr12-112502049-C-T is described in ClinVar as Benign. ClinVar VariationId is 40569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.83 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
NM_002834.5
MANE Select
c.1600-95C>T
intron
N/ANP_002825.3
PTPN11
NM_001330437.2
c.1612-95C>T
intron
N/ANP_001317366.1Q06124-1
PTPN11
NM_001374625.1
c.1597-95C>T
intron
N/ANP_001361554.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTPN11
ENST00000351677.7
TSL:1 MANE Select
c.1600-95C>T
intron
N/AENSP00000340944.3Q06124-2
PTPN11
ENST00000635625.1
TSL:5
c.1612-95C>T
intron
N/AENSP00000489597.1Q06124-1
PTPN11
ENST00000690210.1
c.1600-95C>T
intron
N/AENSP00000509272.1A0A8I5KW48

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55917
AN:
151820
Hom.:
15287
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.724
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.340
Gnomad ASJ
AF:
0.0957
Gnomad EAS
AF:
0.851
Gnomad SAS
AF:
0.297
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.340
GnomAD4 exome
AF:
0.234
AC:
183797
AN:
786298
Hom.:
32404
AF XY:
0.231
AC XY:
95196
AN XY:
411626
show subpopulations
African (AFR)
AF:
0.725
AC:
13733
AN:
18948
American (AMR)
AF:
0.362
AC:
12154
AN:
33548
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
2237
AN:
21060
East Asian (EAS)
AF:
0.828
AC:
28127
AN:
33988
South Asian (SAS)
AF:
0.274
AC:
17987
AN:
65694
European-Finnish (FIN)
AF:
0.156
AC:
7746
AN:
49636
Middle Eastern (MID)
AF:
0.294
AC:
849
AN:
2890
European-Non Finnish (NFE)
AF:
0.174
AC:
91146
AN:
523052
Other (OTH)
AF:
0.262
AC:
9818
AN:
37482
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6317
12634
18951
25268
31585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2262
4524
6786
9048
11310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.369
AC:
56013
AN:
151938
Hom.:
15327
Cov.:
32
AF XY:
0.368
AC XY:
27312
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.725
AC:
30036
AN:
41454
American (AMR)
AF:
0.340
AC:
5191
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.0957
AC:
332
AN:
3468
East Asian (EAS)
AF:
0.851
AC:
4407
AN:
5180
South Asian (SAS)
AF:
0.297
AC:
1430
AN:
4808
European-Finnish (FIN)
AF:
0.153
AC:
1614
AN:
10546
Middle Eastern (MID)
AF:
0.353
AC:
103
AN:
292
European-Non Finnish (NFE)
AF:
0.178
AC:
12058
AN:
67918
Other (OTH)
AF:
0.336
AC:
709
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1317
2635
3952
5270
6587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.260
Hom.:
1620
Bravo
AF:
0.405
Asia WGS
AF:
0.525
AC:
1826
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Noonan syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.14
DANN
Benign
0.21
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3741983;
hg19: chr12-112939853;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.